In the scleroderma group (dcSSc and lcSSc) complicated with calcinosis, anti-Pm/Scl, anti-centromere, and anti-Scl-70 were positive in 7/22, 6/22, and 4/22 patients, respectively. This evidence concerns the gene PRB1 and scleroderma.